Untitled Document Princeton, NJ (Mar. 12)—Sandoz introduced its “Omnitrope Pen 5” with liquid cartridge in the United States. The product was approved by the US Food and Drug Administration and is a new form of the first follow-on version of a recombinant biotechnology drug. The new delivery system contains dissolved...
Link to Article
Pharmaceutical Technology -- Advanstar Communications Inc.
|
|
||||
|
This Month
Month Archive
RSS Newsfeeds
Main Page RSS
|
Thursday, March 20
Sandoz Introduces New Follow-On Version of Recombinant Biotechnology Drug
by
Alex Hsieh on behalf of Professor Henry Wang
on Thu 20 Mar 2008 11:28 PM EDT
FDA Clarifies Its Role in Heparin Investigations
by
Alex Hsieh on behalf of Professor Henry Wang
on Thu 20 Mar 2008 11:26 PM EDT
Untitled Document Rockville, MD (Mar. 14)—Hoping to provide a better understanding of its role in the heparin contamination investigations, the US Food and Drug Administration has posted a series of information sheets on its website. The three documents review the agency’s role in analyzing reports of adverse reactions, collecting and...
Link to Article Pharmaceutical Technology -- Advanstar Communications Inc.
Inhaled TB vaccine shows promising results
by
Alex Hsieh on behalf of Professor Henry Wang
on Thu 20 Mar 2008 11:25 PM EDT
20-Mar-2008 - Animal studies reveal that we may be on the road to creating the first inhaled vaccine for tuberculosis, with results showing the vaccine to be at least as effective as the injected form.
Link to Article in-pharmatechnologist.com |
Search
Links
|
||